Rosuvastatin: do we need another statin?

Issues in emerging health technologies

Volumn , Issue 20, 2001, Pages 1-4

  Ho, C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANADA; COMPARATIVE STUDY; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERCHOLESTEROLEMIA; PHASE 3 CLINICAL TRIAL; TREATMENT OUTCOME; UNITED STATES;

CANADA; CLINICAL TRIALS, PHASE III; DRUG APPROVAL; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0035411001     PISSN: 14886324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)